Founded by Filippo Surace M.D., Cube Labs’ initial capital injection was by Filippo Surace and Gruppo Surace, a distinguished group in physical and rehabilitation medicine and homecare health services in Italy.
By nature of their academic roots, Cube Labs portfolio companies have received and continue to receive non-dilutive R&D funding from Italy and the EU.
Cube Labs portfolio companies’ have access to in kind resources from academic networks in the forms of knowhow, equipment and laboratory space.
Cube Labs raised capital in 2015 through family and friends.
Cube Labs closed a funding round in April 2020 through the Club Deal “Cube Labs Ambassadors,” via professionals and business angel investors.
Cube Labs and its portfolio companies have benefitted from support granted by local and international banks to qualified innovative SMEs and innovative startups.
In July 2020, Cube Labs and CDP Venture Capital - National Innovation Fund signed a joint investment agreement to support pre-seed and seed stage innovative life science startups in Southern Italy. Five companies will be supported through this joint investment.
Series A round is expected to close Q2 – 2021. Further rounds from investors and/or the capital markets are planned.